{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:52:00Z","timestamp":1786978320981,"version":"build-2736575974"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":258,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26461384"],"award-info":[{"award-number":["26461384"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007591","name":"Akiyama Life Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007591","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012627","name":"Japan Diabetes Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012627","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008664","name":"Ono Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008664","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obesity"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1002\/oby.20954","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T01:48:40Z","timestamp":1418953720000},"page":"359-367","source":"Crossref","is-referenced-by-count":91,"title":["FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms"],"prefix":"10.1002","volume":"23","author":[{"given":"Tomohiro","family":"Mita","sequence":"first","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Hiramitsu","sequence":"additional","affiliation":[{"name":"Hiramitsu Heart Clinic; Shiroshita-cho 2-35, Minami-ku Nagoya 457-0047 Aichi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnichi","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Joint Research Laboratory of Clinical Medicine; Fujita Health University School of Medicine; Toyoake 470-1192 Aichi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hoshina","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutaro","family":"Ishimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fuseya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Akasaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"},{"name":"Department of Public Health; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"},{"name":"Department of Nursing; Division of Medical and Behavioral Subjects; Sapporo Medical University School of Health Sciences; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Shimamoto","sequence":"additional","affiliation":[{"name":"Sapporo Medical University; S-1, W-16 Chuo-ku Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular; Renal and Metabolic Medicine; Sapporo Medical University School of Medicine; Sapporo 060-8543 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"10.1002\/oby.20954-BIB0001|oby20954-cit-0001","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/oby.20954-BIB0002|oby20954-cit-0002","doi-asserted-by":"crossref","first-page":"642612","DOI":"10.4061\/2011\/642612","article-title":"Lipid chaperones and metabolic inflammation","volume":"2011","author":"Furuhashi","year":"2011","journal-title":"Int J Inflam"},{"key":"10.1002\/oby.20954-BIB0003|oby20954-cit-0003","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","article-title":"Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein","volume":"274","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"10.1002\/oby.20954-BIB0004|oby20954-cit-0004","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/89076","article-title":"Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis","volume":"7","author":"Makowski","year":"2001","journal-title":"Nat Med"},{"key":"10.1002\/oby.20954-BIB0005|oby20954-cit-0005","first-page":"2640","article-title":"Adipocyte\/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice","volume":"118","author":"Furuhashi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1002\/oby.20954-BIB0006|oby20954-cit-0006","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.0000141735.13202.B6","article-title":"Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice","volume":"110","author":"Boord","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/oby.20954-BIB0007|oby20954-cit-0007","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature05844","article-title":"Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2","volume":"447","author":"Furuhashi","year":"2007","journal-title":"Nature"},{"key":"10.1002\/oby.20954-BIB0008|oby20954-cit-0008","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","article-title":"Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome","volume":"52","author":"Xu","year":"2006","journal-title":"Clin Chem"},{"key":"10.1002\/oby.20954-BIB0009|oby20954-cit-0009","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","article-title":"Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production","volume":"17","author":"Cao","year":"2013","journal-title":"Cell Metab"},{"key":"10.1002\/oby.20954-BIB0010|oby20954-cit-0010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ijo.2013.232","article-title":"Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism","volume":"38","author":"Kralisch","year":"2014","journal-title":"Int J Obes"},{"key":"10.1002\/oby.20954-BIB0011|oby20954-cit-0011","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/ijo.2013.241","article-title":"Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes","volume":"38","author":"Schlottmann","year":"2014","journal-title":"Int J Obes"},{"key":"10.1002\/oby.20954-BIB0012|oby20954-cit-0012","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.109.200501","article-title":"Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: A new link between obesity and heart disease","volume":"105","author":"Lamounier-Zepter","year":"2009","journal-title":"Circ Res"},{"key":"10.1002\/oby.20954-BIB0013|oby20954-cit-0013","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","article-title":"Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: A 5-year prospective study","volume":"115","author":"Xu","year":"2007","journal-title":"Circulation"},{"key":"10.1002\/oby.20954-BIB0014|oby20954-cit-0014","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2337\/dc07-0413","article-title":"Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: A 10-year prospective study in a Chinese cohort","volume":"30","author":"Tso","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1002\/oby.20954-BIB0015|oby20954-cit-0015","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1161\/ATVBAHA.112.248609","article-title":"Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: A 10-year prospective study","volume":"32","author":"Eynatten","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/oby.20954-BIB0016|oby20954-cit-0016","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ajh.2012.88","article-title":"Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation","volume":"25","author":"Ota","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1002\/oby.20954-BIB0017|oby20954-cit-0017","doi-asserted-by":"crossref","first-page":"e81318","DOI":"10.1371\/journal.pone.0081318","article-title":"Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population","volume":"8","author":"Ishimura","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1002\/oby.20954-BIB0018|oby20954-cit-0018","doi-asserted-by":"crossref","first-page":"e27356","DOI":"10.1371\/journal.pone.0027356","article-title":"Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease","volume":"6","author":"Furuhashi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1002\/oby.20954-BIB0019|oby20954-cit-0019","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-014-0126-7","article-title":"Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population","volume":"13","author":"Fuseya","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1002\/oby.20954-BIB0020|oby20954-cit-0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jjcc.2012.07.010","article-title":"Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load","volume":"60","author":"Hiramitsu","year":"2012","journal-title":"J Cardiol"},{"key":"10.1002\/oby.20954-BIB0021|oby20954-cit-0021","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1002\/oby.20954-BIB0022|oby20954-cit-0022","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1079\/PNS2004350","article-title":"Physiological regulation of NEFA availability: Lipolysis pathway","volume":"63","author":"Stich","year":"2004","journal-title":"Proc Nutr Soc"},{"key":"10.1002\/oby.20954-BIB0023|oby20954-cit-0023","doi-asserted-by":"crossref","first-page":"H358","DOI":"10.1152\/ajpheart.00704.2012","article-title":"Natriuretic peptides and cGMP signaling control of energy homeostasis","volume":"304","author":"Moro","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1002\/oby.20954-BIB0024|oby20954-cit-0024","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1073\/pnas.96.10.5528","article-title":"Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein","volume":"96","author":"Shen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/oby.20954-BIB0025|oby20954-cit-0025","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2337\/diabetes.48.10.1987","article-title":"Altered insulin secretion associated with reduced lipolytic efficiency in aP2-\/- mice","volume":"48","author":"Scheja","year":"1999","journal-title":"Diabetes"},{"key":"10.1002\/oby.20954-BIB0026|oby20954-cit-0026","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-2275(20)32133-7","article-title":"Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels","volume":"40","author":"Coe","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1002\/oby.20954-BIB0027|oby20954-cit-0027","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev"},{"key":"10.1002\/oby.20954-BIB0028|oby20954-cit-0028","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrm2617","article-title":"Mechanisms of regulated unconventional protein secretion","volume":"10","author":"Nickel","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1002\/oby.20954-BIB0029|oby20954-cit-0029","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2362.2007.01835.x","article-title":"Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia","volume":"37","author":"Karpisek","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1002\/oby.20954-BIB0030|oby20954-cit-0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00380-010-0060-x","article-title":"Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients","volume":"26","author":"Miyoshi","year":"2011","journal-title":"Heart Vessels"}],"container-title":["Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Foby.20954","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/oby.20954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T12:21:31Z","timestamp":1650802891000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.20954"}},"subtitle":["FABP4 Secretion from Adipocytes and Lipolysis"],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1002\/oby.20954","relation":{},"ISSN":["1930-7381"],"issn-type":[{"value":"1930-7381","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,17]]}}}